GlassScriptPhysician profile
William Britt Zimmerman
NPI 1285803627
$4,237.10
in general payments reported to CMS, 2019-2025
21 companies · $488 in 2025
The $488 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,471 · 2020: $54.65 · 2021: $156 · 2022: $276 · 2023: $327 · 2024: $462 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,278.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $2,170.92 | 2019-2025 | Porges Coloplast, Speedicath |
| Boston Scientific Corporation | $748.73 | 2019-2023 | |
| Olympus America INC. | $228.08 | 2024-2025 | Itind System |
| Axonics, INC. | $165.89 | 2021-2023 | Axonics |
| Neotract INC. | $142.77 | 2019-2020 | |
| Photocure INC | $132.45 | 2019-2024 | Cysview |
| Endo USA, INC. | $91.70 | 2024-2025 | Xiaflex, Aveed |
| Janssen Scientific Affairs, LLC | $88.70 | 2025 | |
| Medtronic, INC. | $76.28 | 2022-2025 | Ligasure, Interstim |
| Olympus Corporation of The Americas | $65.00 | 2023 | Itind System |
| Laborie Medical Technologies Corp. | $50.46 | 2022-2025 | Endosheath Technology |
| Endo Pharmaceuticals INC. | $43.40 | 2022-2023 | Edex, Xiaflex, Aveed |
| Abbvie INC. | $40.24 | 2022-2023 | Botox |
| Karl Storz Endoscopy-America | $35.06 | 2019 | |
| Glaxosmithkline, LLC. | $34.00 | 2024 | Nucala |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $32.34 | 2022 | |
| Calyxo, INC. | $23.99 | 2025 | Cvac Aspiration System |
| Abc Home Medical Supply, INC. | $22.14 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.73 | 2023 | Xifaxan |
| Rochester Medical Corporation | $12.90 | 2020 | |
| Astellas Pharma US INC | $11.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Zimmerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.